AVTR-101

N/A

Report date: 2025/02/25 16:56:32
NME

Base Information

Drug NameAVTR-101
Drug Alias NameAVTR101AVTR-101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSarcopenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAventi Biotechnology Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAventi Biotechnology Inc
Active IndicationsN/A
Inactive IndicationsSarcopenia

Other Information

ATC CodeN/A
Related LinksN/A